Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Radius Residential Care Limited (RAD.NZ)
Auckland, NZ
Headquartered in Auckland, New Zealand, Radius Residential Care Limited has been a prominent provider of health and elder care services across the country since its establishment in 2003. The company focuses on supporting elderly and disabled individuals, delivering a comprehensive range of offerings including residential, hospital-level, dementia-specific, respite, and palliative care, as well as general rest home and private hospital services. Its extensive operations encompass 23 aged care facilities, collectively offering approximately 1,780 care beds, alongside three retirement villages that feature 101 independent living units. Additionally, Radius manages an e-commerce platform dedicated to specialized assisted living products.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +3.90% | +2.56% | -2.44% | +2.56% | +42.86% | +60.00% | -55.56% | -77.14% | -77.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+12.9% ★ Q1'26: +16.5% (vs Q1'24)
-
EPS growth Medical - Care Facilities: +19.2%+34.8% ★ Q1'26: +115.8% (vs Q1'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+4.3% Q1'26: +0.3% (vs Q1'24)
-
EBIT margin Medical - Care Facilities: +11.3%+10.3% Q1'26: +8.9% (vs Q1'24)
-
ROIC Medical - Care Facilities: +6.8%+5.0% Q1'26: +7.5% (vs Q1'24)
-
Share dilution Medical - Care Facilities: +0.0%-0.4% ★ Q1'26: -0.5% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×6.32× Q1'26: 3.24× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 1 EPS Ana. |
Mar 2027 2 Rev. Ana. 1 EPS Ana. |
Mar 2028 2 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. |
|---|---|---|---|---|---|
| Revenue |
177.30M
est: 171.66M (+3.3%)
|
205.01M
204.89M – 205.12M
+19.4% YoY
|
219.05M
216.83M – 221.28M
+6.9% YoY
|
229.67M
224.66M – 234.69M
+4.8% YoY
|
249.18M
245.16M – 253.20M
+8.5% YoY
|
| EBITDA |
27.09M
est: 27.13M (-0.1%)
|
32.40M
32.38M – 32.42M
+19.4% YoY
|
34.62M
34.27M – 34.97M
+6.9% YoY
|
36.30M
35.50M – 37.09M
+4.8% YoY
|
39.38M
38.74M – 40.01M
+8.5% YoY
|
| EBIT |
16.69M
est: 15.27M (+9.3%)
|
18.23M
18.22M – 18.24M
+19.4% YoY
|
19.48M
19.28M – 19.68M
+6.9% YoY
|
20.43M
19.98M – 20.87M
+4.8% YoY
|
22.16M
21.80M – 22.52M
+8.5% YoY
|
| Net Income |
7.03M
est: 7.37M (-4.5%)
|
11.68M
10.50M – 12.85M
+58.5% YoY
|
11.15M
9.37M – 12.92M
-4.5% YoY
|
12.83M
10.22M – 15.44M
+15.1% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
107.30M
est: 65.85M (+62.9%)
|
78.64M
78.60M – 78.69M
+19.4% YoY
|
84.03M
83.18M – 84.88M
+6.9% YoY
|
88.11M
86.18M – 90.03M
+4.8% YoY
|
95.59M
94.05M – 97.13M
+8.5% YoY
|
| EPS |
0.02
est: 0.03 (-4.8%)
|
0.04
0.04 – 0.05
+58.5% YoY
|
0.04
0.03 – 0.05
-4.6% YoY
|
0.05
0.04 – 0.05
+15.1% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrew W. Peskett | Chief Executive Officer | 573.3K | male |
| Duncan Robert Cook | Executive Director | 212.0K | male |
| Brien Cree | Founder & Executive Chair | — | male |
| Jeremy Edmonds | Chief Financial Officer | — | male |
| Richard Callander | Chief Operations Officer | — | male |
| Sam Carey | General Manager of Revenue | — | male |
| Trish Evers | General Manager of People | — | female |
| Antony Challinor | Chief Digital Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RAD.NZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
